American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4003)
  2. Hematologic Malignancies, Division of (3806)
  3. Center for Hematologic Malignancies (3683)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1345)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (989)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1261)
  3. Research Letter (46)
  4. Review (43)
  5. Editorial (35)
  6. Guidelines (14)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4003)
  2. Hematologic Malignancies, Division of (3806)
  3. Center for Hematologic Malignancies (3683)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1345)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (349)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (68)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5175)
  2. Blood Advances (334)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5559)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Importance of achieving complete remission (CR) after intensive therapy for acute myeloid leukemia (AML) in older adults age >= 60 years: Analysis of risk factors for early mortality and re-induction, and impact of quality of response on overall survival (OS) in the ECOG-ACRIN E2906 randomized trial
    Meeting Abstract

    Foran, J. M.; Sun, Z.; Claxton, D. F.; Lazarus, H. M.; Thomas, M. L.; Melnick, A.; Levine, R. L.; Paietta, E.; Arber, D. A.; Zhang, Y.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Mutational analysis of clonal hematopoiesis in solid tumor patients illustrates the critical role of systemic anti-cancer therapies in the evolution of somatic leukemia disease alleles
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; Arcila, M.; Tallman, M. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Risk of bleeding in 9,429 patients with Philadelphia-negative myeloproliferative neoplasms: A population-based study from Sweden
    Meeting Abstract

    Creignou, M.; Bower, H.; Andersson, T. M. L.; Landtblom, A. R.; Dickman, P. W.; Björkholm, M.; Kristinsson, S. Y.; Hultcrantz, M.
    Blood (2016)

    Fulltext@MSK | Save
  • MYC-dependent PI3K and MCL-1 feedbacks attenuate BET inhibitors activity in diffuse large B-cell lymphoma
    Meeting Abstract

    Derenzini, E.; Mondello, P.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Djaballah, H.; Ouerfelli, O.; de Stanchina, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Vemurafenib in patients with Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study
    Meeting Abstract

    Diamond, E. L.; Subbiah, V.; Lockhart, C.; Blay, J. Y.; Faris, J. E.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J. S.; Erinjeri, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Determination of IDH1 mutational burden and clearance via next-generation sequencing in patients with IDH1 mutation-positive hematologic malignancies receiving AG-120, a first-in-class inhibitor of mutant IDH1
    Meeting Abstract

    DiNardo, C. D.; de Botton, S.; Stein, E. M.; Roboz, G. J.; Swords, R. T.; Pollyea, D. A.; Fathi, A. T.; Collins, R.; Altman, J. K.; Flinn, I. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Isogenic iPSC models of SRSF2-mutant myelodysplastic syndrome capture disease phenotypes, splicing defects and drug responses
    Meeting Abstract

    Chang, C. J.; Kotini, A.; Teruya-Feldstein, J.; Abdel-Wahab, O.; Bradley, R.; Papapetrou, E. P.
    Blood (2016)

    Fulltext@MSK | Save
  • Hemophagocytic lymphohistiocytosis (HLH) in Langerhans cell histiocytosis (LCH): A multicenter retrospective descriptional study
    Meeting Abstract

    Chellapandian, D.; Zhang, R.; Jeng, M.; Van den Bos, C.; López, V. S. M.; Lehmberg, K.; Sieni, E.; Wang, Y.; Nakano, T. A.; Williams, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • An epigenetic regulator screen identifies novel targets that sensitize MLL-rearranged leukemia to DOT1L inhibition
    Meeting Abstract

    Chen, C. W. D.; Delaney, C.; Xu, H.; Koche, R.; Goizueta, A. L.; Hoshii, T.; Cusan, M.; Chabon, J.; Valerio, D. G.; Kuehn, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Loss of lysine histone methyltransferase SETD2 disrupts normal hematopoiesis, lineage commitment and reveals a novel role for H3K36me3 in immunoglobulin VDJ recombination
    Meeting Abstract

    Chu, S. H.; Chabon, J. R.; Minehart, J.; Koche, R.; Li, K.; Witkin, M.; Krivtsov, A.; Armstrong, S. A.
    Blood (2016)

    Fulltext@MSK | Save